Exhibit 8
Dr. Reddy’s Laboratories Limited
Dr. Reddy’s Laboratories Limited is the parent company. Tabulated below is the list of subsidiaries, associates and joint ventures as of March 31, 2016:
Name of the subsidiary | Country of | Percentage of Direct/Indirect Ownership Interest | ||||
Aurigene Discovery Technologies (Malaysia) Sdn. Bhd. | Malaysia | 100 | %(3) | |||
Aurigene Discovery Technologies Inc. | U.S.A. | 100 | %(3) | |||
Aurigene Discovery Technologies Limited | India | 100 | % | |||
beta Institut gemeinnützige GmbH | Germany | 100 | %(8) | |||
betapharm Arzneimittel GmbH | Germany | 100 | %(8) | |||
Cheminor Investments Limited | India | 100 | % | |||
Chienna B.V. | Netherlands | 100 | %(13) | |||
Chirotech Technology Limited | United Kingdom | 100 | %(5) | |||
DRANU LLC | U.S.A. | 50 | %(15) | |||
Dr. Reddy’s Bio-Sciences Limited | India | 100 | % | |||
Dr. Reddy’s Farmaceutica Do Brasil Ltda. | Brazil | 100 | % | |||
Dr. Reddy’s Laboratories (Australia) Pty. Limited | Australia | 100 | %(10) | |||
Dr. Reddy’s Laboratories Canada, Inc. | Canada | 100 | %(10) | |||
Dr. Reddy’s Laboratories (EU) Limited | United Kingdom | 100 | %(10) | |||
Dr. Reddy’s Laboratories Inc. | U.S.A. | 100 | %(10) | |||
Dr. Reddy’s Laboratories International SA | Switzerland | 100 | %(10) | |||
Dr. Reddy’s Laboratories Japan KK (from April 21, 2015) | Japan | 100 | %(10) | |||
Dr. Reddy’s Laboratories, LLC | Ukraine | 100 | %(10) | |||
Dr. Reddy’s Laboratories Louisiana LLC | U.S.A. | 100 | %(6) | |||
Dr. Reddy’s Laboratories New York, Inc. | U.S.A. | 100 | %(10) | |||
Dr. Reddy’s Laboratories (Proprietary) Limited | South Africa | 100 | %(10) | |||
Dr. Reddy’s Laboratories Romania S.R.L. | Romania | 100 | %(10) | |||
Dr. Reddy’s Laboratories SA | Switzerland | 100 | % | |||
Dr. Reddy’s Laboratories SAS (from November 4, 2014) | Colombia | 100 | %(10) | |||
Dr. Reddy’s Laboratories Tennessee, LLC | U.S.A. | 100 | %(6) | |||
Dr. Reddy’s Laboratories (UK) Limited | United Kingdom | 100 | %(5) | |||
Dr. Reddy’s New Zealand Limited. | New Zealand | 100 | %(10) | |||
Dr. Reddy’s Pharma SEZ Limited | India | 100 | % | |||
Dr. Reddy’s Singapore PTE Limited | Singapore | 100 | %(10) | |||
Dr. Reddy’s Srl | Italy | 100 | %(11) | |||
Dr. Reddy’s Venezuela, C.A. | Venezuela | 100 | %(10) | |||
DRL Impex Limited | India | 100 | % | |||
Eurobridge Consulting B.V. | Netherlands | 100 | %(1) | |||
Industrias Quimicas Falcon de Mexico, S.A. de CV | Mexico | 100 | % | |||
Idea2Enterprises (India) Pvt. Limited | India | 100 | % | |||
Kunshan Rotam Reddy Pharmaceutical Co. Limited | China | 51.33 | %(4) | |||
Lacock Holdings Limited | Cyprus | 100 | %(10) | |||
OOO Dr. Reddy’s Laboratories Limited | Russia | 100 | %(10) | |||
OOO DRS LLC | Russia | 100 | %(9) | |||
OctoPlus B.V. (formerly OctoPlus N.V.) | Netherlands | 100 | %(12) | |||
OctoPlus Development B.V. | Netherlands | 100 | %(13) | |||
OctoPlus Sciences B.V. | Netherlands | 100 | %(13) | |||
OctoPlus PolyActive Sciences B.V. | Netherlands | 100 | %(14) | |||
OctoPlus Technologies B.V. | Netherlands | 100 | %(13) | |||
OctoShare B.V. | Netherlands | 100 | %(13) | |||
Promius Pharma LLC | U.S.A. | 100 | %(6) | |||
Reddy Antilles N.V. | Netherlands | 100 | % | |||
Reddy Specialities GmbH (till November 21, 2015) | Germany | 100 | %(8) | |||
Reddy Cheminor S.A. | France | 100 | %(2) | |||
Reddy Holding GmbH | Germany | 100 | %(10) | |||
Reddy Netherlands B.V. | Netherlands | 100 | %(10) |
Name of the subsidiary | Country of | Percentage of Direct/Indirect Ownership Interest | ||||
Reddy Pharma Iberia SA | Spain | 100 | % | |||
Reddy Pharma Italia S.R.L. (formerly Reddy Pharma Italia S.p.A.) | Italy | 100 | %(7) | |||
Reddy Pharma SAS (from October 29, 2015) | France | 100 | %(10) | |||
DRSS Solar Power Private Limited | India | 26 | %(16) | |||
DRES Solar Power Private Limited (from October 6, 2015) | India | 26 | %(16) |
(1) | Indirectly owned through Reddy Antilles N.V. |
(2) | Subsidiary under liquidation. |
(3) | Indirectly owned through Aurigene Discovery Technologies Limited. |
(4) | Kunshan Rotam Reddy Pharmaceutical Co. Limited is a subsidiary, as we hold a 51.33% stake. However, we account for this investment by the equity method and do not consolidate it in our financial statements. |
(5) | Indirectly owned through Dr. Reddy’s Laboratories (EU) Limited. |
(6) | Indirectly owned through Dr. Reddy’s Laboratories Inc. |
(7) | Indirectly owned through Lacock Holdings Limited. |
(8) | Indirectly owned through Reddy Holding GmbH. |
(9) | Indirectly owned through Eurobridge Consulting B.V. |
(10) | Indirectly owned through Dr. Reddy’s Laboratories SA. |
(11) | Indirectly owned through Reddy Pharma Italia S.R.L. |
(12) | Indirectly owned through Reddy Netherlands B.V. |
(13) | Indirectly owned through OctoPlus B.V. |
(14) | Indirectly owned through OctoPlus Sciences B.V. |
(15) | DRANU LLC is consolidated in accordance with guidance available in IFRS 10. |
(16) | Accounted in accordance with IFRS 11 ‘Joint Arrangements’. |